early-stage prostate cancer

November 14, 2019November 14, 2019

Enrollment Completed for Phase 3 Trial Testing Provenge in Prostate Cancer Patients on Active Surveillance

News

Dendreon Pharmaceuticals has completed patient enrollment ahead of schedule in an ongoing Phase 3 trial assessing the safety and efficacy of its immunotherapy Provenge (sipuleucel-T) for men with early-stage prostate ... Read more

July 16, 2018July 16, 2018

Phase 2 Trial of Potential Prostate Cancer Vaccine, ProscaVax, Soon to Enroll Early-stage Patients

News

OncBioMune Pharmaceuticals will soon start a Phase 2 clinical trial of its investigational vaccine ProscaVax in people with early-stage prostate cancer. ProscaVax consists of a combination of the PSA protein (a ... Read more

February 9, 2018February 9, 2018

Noninvasive Blood Test Enables Early Detection of Prostate Cancer, Study Suggests

News

A new, noninvasive blood test can reliably detect prostate cancer in patients with inconclusive PSA tests, the test’s developer, CellMax Life, recently announced. Researchers say the company’s circulating tumor cell (CTC) ... Read more

December 21, 2016December 21, 2016

Laser-guided Treatment, VTP, May Be Alternative to Monitoring or Surgery for Low-risk Prostate Cancers

News

A new therapeutic approach called vascular-targeted photodynamic therapy (VTP) could be used to treat early-stage prostate cancer according to a study published in the leading medical journal The Lancet Oncology. ... Read more